EXCELSIOR BIOPHARMA INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.95 TWD | -0.36% |
|
+0.72% | -3.12% |
| Sales 2022 | 672M 20.59M 1.72B | Sales 2023 | 772M 23.65M 1.97B | Capitalization | 1.36B 41.58M 3.47B |
|---|---|---|---|---|---|
| Net income 2022 | -33M -1.01M -84.44M | Net income 2023 | -91M -2.79M -233M | EV / Sales 2022 | 0.81 x |
| Net cash position 2022 | 755M 23.15M 1.93B | Net cash position 2023 | 236M 7.22M 603M | EV / Sales 2023 | 1.45 x |
| P/E ratio 2022 |
-37.6
x | P/E ratio 2023 |
-14.6
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 38.76% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.36% | ||
| 1 week | +0.72% | ||
| Current month | -0.36% | ||
| 1 month | -0.36% | ||
| 3 months | -1.06% | ||
| 6 months | -2.61% | ||
| Current year | -3.12% |
1 week
27.70
28.50
1 month
27.0028.50
Current year
27.0029.65
1 year
27.0036.30
3 years
25.8036.45
5 years
22.2552.20
10 years
22.25151.45
| Managers | Title | Age | Since |
|---|---|---|---|
Tse Min Chen
CEO | Chief Executive Officer | - | 21/88/21 |
Ming Tse Chen
DFI | Director of Finance/CFO | - | - |
Hui Chen Liu
ADM | Chief Administrative Officer | - | 04/12/04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hsiu Hui Li
BRD | Director/Board Member | - | 04/12/04 |
Man Hsiang Li
BRD | Director/Board Member | - | 04/12/04 |
Hsi Chieh Wang
BRD | Director/Board Member | - | 04/12/04 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 27.95 | -0.36% | 10,449 |
| 29/24/29 | 28.05 | -1.06% | 24,432 |
| 26/24/26 | 28.35 | +2.35% | 30,347 |
| 25/24/25 | 27.7 | -.--% | 14,507 |
| 24/24/24 | 27.7 | -0.36% | 13,827 |
End-of-day quote Taipei Exchange, April 30, 2024
More quotes
Excelsior Biopharma Inc. is a Taiwan-based company principally engaged in the research, development, production and sales of prescription drugs. The Company's main products include prescription drugs, non-prescription drugs, health care products, medical equipment and rapid test reagents. The Company distributes its product in domestic market and to overseas markets.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -3.12% | 40.26M | |
| +34.00% | 704B | |
| +29.29% | 577B | |
| -7.75% | 348B | |
| +18.53% | 327B | |
| +4.95% | 288B | |
| +13.79% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.89% | 147B |
- Stock Market
- Equities
- 6496 Stock
